Texas A&M Football

Lunch with Liucci: Billy Liucci joins TexAgs Radio (Monday, December 4)

TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio Monday morning to provide an update on all things Texas A&M football. Liucci discussed the College Football Playoff, Elijah Robinson leaving for Syracuse and more.
By Billy Liucci
December 4, 2023
11k Views
Discuss
Story Poster

TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio Monday morning to provide an update on all things Texas A&M football. Liucci discussed the College Football Playoff, Elijah Robinson leaving for Syracuse and more.


Segment 1 (00:00:00 - 10:45:21)

  • I have a lot of thoughts on Texas in the playoffs. They are deserving by the way it's set up. They deserved to be in over Alabama. You could argue Florida State.
To watch this video, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Dameyune Craig Mike Elko Sean Spencer Elijah Robinson Tyler Santucci TexAgs Live David Nuño 12th Man Foundation TexAgs Live Feature College Football Playoff Jimbo Fisher Lunch with Liucci
Show All
Trevor Lawrence Steve Sarkisian College Football Playoff rankings Brian Kelly Jordan Travis Andy Katz McKinnley Jackson Evan Stewart Walter Nolen Cameron Coleman Cameron Coleman Football Basketball Texas A&M Oklahoma State Texas Washington Georgia Virginia Louisville Florida State Michigan Ohio State Alabama Memphis Florida Atlantic 2023
SPONSORED BY
12th Man Foundation
More Football
See All →
Defense in Review: Texas 27, Texas A&M 17
By Sean Porter
B-Team: Coaching carousel hits high gear, quotable movies & more
By Ryan Brauninger
Texas A&M drops four spots to No. 7 following rivalry week loss
By Richard Zane
Tight end Kiotti Armstrong shares what he has learned as a freshman
By Ryan Brauninger
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.